Sign In
Buy MRTX
$58.70
+0 (+0%)
At Close: Apr 19, 2024
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Intuitive Surgical (
ISRG
–
Research Report
), Frequency Therapeutics (
FREQ
–
Research Report
) an
Here is What Hedge Funds Think About World Wrestling Entertainment, Inc. (WWE)
05:07pm, Thursday, 26'th Mar 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Hedge Funds Have Never Been This Bullish On Tech Data Corp (TECD)
05:07pm, Thursday, 26'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Is Mirati Therapeutics, Inc. (MRTX) A Good Stock To Buy?
05:06pm, Thursday, 26'th Mar 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Top Drug Stocks Under $5
11:36am, Thursday, 26'th Mar 2020
Healthcare bargain hunters can find good values in quality low-priced stocks.
Amalgamated Bank Has $631,000 Stake in Mirati Therapeutics Inc (NASDAQ:MRTX)
09:14am, Thursday, 26'th Mar 2020
Amalgamated Bank lifted its stake in shares of Mirati Therapeutics Inc (NASDAQ:MRTX) by 10.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Comm
Amundi Pioneer Asset Management Inc. Purchases Shares of 234,163 Mirati Therapeutics Inc (NASDAQ:MRTX)
08:38am, Saturday, 21'st Mar 2020
Amundi Pioneer Asset Management Inc. purchased a new stake in Mirati Therapeutics Inc (NASDAQ:MRTX) in the 4th quarter, according to its most recent filing with the SEC. The fund purchased 234,163 sha
Klinik Health Ventures Corp. Announces Qualifying Transaction
09:13pm, Friday, 20'th Mar 2020
The LOI outlines the principal terms and conditions which will result in a reverse takeover of Klinik by NeuPath (the "Transaction"). Klinik is a Capital Pool Company and intends for the Transaction
Design Therapeutics Launches with $45 Million to Develop a New Class of Disease-Modifying Therapies for Serious Degenerative Disorders
Mirati Therapeutics (NASDAQ:MRTX) Upgraded at JPMorgan Chase & Co.
07:30am, Monday, 16'th Mar 2020
JPMorgan Chase & Co. upgraded shares of Mirati Therapeutics (NASDAQ:MRTX) from an underweight rating to a neutral rating in a research report report published on Thursday morning, BenzingaRatingsTable
Mirati Therapeutics (NASDAQ:MRTX) Shares Down 10.6%
08:02am, Friday, 13'th Mar 2020
Mirati Therapeutics Inc (NASDAQ:MRTX)’s share price fell 10.6% during trading on Wednesday . The company traded as low as $76.78 and last traded at $77.37, 623,700 shares traded hands during mid-day
